Roche Holding AG (RHHBY) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Drug Manufacturers - General Branche. Der Hauptsitz des Unternehmens ist in Basel, Switzerland. Der aktuelle CEO ist Thomas Schinecker.
RHHBY hat IPO-Datum 2003-08-20, 103,249 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $328.61B.
Roche Holding AG is a Swiss multinational pharmaceutical and diagnostics company founded in 1896 and headquartered in Basel. The company develops and markets pharmaceutical products across multiple therapeutic areas including oncology, neuroscience, immunology, cardiovascular and metabolism, ophthalmology, and respiratory diseases, as well as treatments for conditions such as cancer, hemophilia, and inflammatory disorders. In addition to pharmaceuticals, Roche operates a substantial diagnostics business offering in vitro tests for disease diagnosis including cancer, diabetes, COVID-19, and hepatitis, alongside diagnostic instruments and reagents. The company serves patients and healthcare providers across Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and numerous other markets globally.
